Despite the global prevalence of gastric disease, there are few adequate models in which to study the fundus epithelium of the human stomach. We differentiated human pluripotent stem cells (hPSCs) into gastric organoids containing fundic epithelium by first identifying and then recapitulating key events in embryonic fundus development. We found that disruption of Wnt/β-catenin signalling in mouse embryos led to conversion of fundic to antral epithelium, and that β-catenin activation in hPSC-derived foregut progenitors promoted the development of human fundic-type gastric organoids (hFGOs). We then used hFGOs to identify temporally distinct roles for multiple signalling pathways in epithelial morphogenesis and differentiation of fundic cell types, including chief cells and functional parietal cells. hFGOs are a powerful model for studying the development of the human fundus and the molecular bases of human gastric physiology and pathophysiology, and also represent a new platform for drug discovery.
Recently, considerable progress has been made in the development of three-dimensional in vitro organoid systems 1, 2 . Organoids have proven to be powerful experimental models that combine architectural complexity and cellular diversity with the tractability and scalability of traditional cell culture methods. Generation of organoids through directed differentiation of pluripotent stem cells (PSCs; comprising both embryonic stem cells and induced PSCs) offers several advantages over other approaches, including an unlimited source of starting material, the absence of a requirement for surgical acquisition of tissue, and ease of genetic manipulation. Furthermore, PSC-based methods permit direct investigation of the mechanisms that underlie normal and aberrant human development 3 . However, differentiating PSCs into specific organoid types depends on a robust molecular understanding of normal organ development. For some organs, such as the stomach, there are large gaps in our understanding of the molecular pathways that drive embryonic development.
The stomach is one of the most structurally diverse organs in mammals 4 . In humans, the gastric mucosa generally consists of two types of epithelial glands 5, 6 . Located in the more proximal anatomical domains-the corpus and fundus-of the stomach, oxyntic glands comprise acid-secreting parietal cells, protease-producing chief cells, mucus-producing cells, and endocrine cells. Antral-type glands, located in the more distal antrum and pylorus, contain mostly mucous and endocrine cells. To simplify the anatomy-and species-specific systems of nomenclature, we will use the terms 'fundus' and 'antrum' to broadly describe these two histologic types of gastric epithelia. We previously developed a method to direct the differentiation of hPSCs into threedimensional gastric tissue (human gastric organoids; hGOs) that contained a pure antral epithelium with normal antral cell types 7 . Although these antral hGOs (hAGOs) are a robust system in which to study antral lineage allocation and host-microbe interactions in the stomach, they do not allow studies of fundic biology and disease. More recently, Noguchi et. al. successfully differentiated mouse embryonic stem cells (ESCs) into organoids comprising various types of mouse gastric tissue 8 . However, this approach used mouse ESC aggregation and spontaneous differentiation, resulting in organoids that were heterogeneous, as shown by the presence of stratified epithelia. Moreover, species differences make the mouse stomach suboptimal for modelling human gastric disease 9 . Thus, a robust and efficient PSC-derived model of the human fundus epithelium would represent a significant advance in gastric biology research.
Embryonic organ development is guided by a series of instructive cues between neighbouring tissues 10, 11 , and differentiation of hPSCs into specific lineages has relied heavily on use of these signals to direct differentiation in vitro. We previously identified a step-wise differentiation approach to generate hAGOs, whereby hPSCs were differentiated into definitive endoderm, patterned to posterior foregut, then specified into presumptive antral epithelium 7 . We hypothesized that the fundus and antrum derive from a common population of posterior foregut progenitors, which could be directed towards the fundic lineage if provided with the appropriate signals. However, given that the mechanisms that drive fundus development in vivo were not previously known, we first had to identify signalling pathways that pattern the embryonic stomach along the proximal-distal axis.
Embryonic stomach pattern formation
To investigate the pathways that regulate fundus specification during embryonic development, we analysed mouse embryos to identify molecular markers that could distinguish between presumptive fundus, antrum and forestomach. At embryonic day (E)14.5, Sox2 was expressed in all foregut organ lineages whereas Gata4 was restricted to the glandular stomach epithelium. Within the Gata4 + domain, Pdx1 was specific to the presumptive antral region (Extended Data Fig. 1a ); thus, the embryonic fundus domain is Sox2 + Gata4 + Pdx1 − . We also analysed published microarray data sets (GSM326648-GSM326650 12 and GSM80809-GMS80816 13 ) and dissected regions of the E14.5 foregut to demonstrate that expression of the transcription factors Irx2, Irx3 and Irx5 was more than tenfold higher in the embryonic fundus than in the antrum (Extended Data Fig. 1b, c) , indicating that expression of these transcription factors can further distinguish between regions of the glandular gastric epithelium.
At the molecular level, the presumptive fundic and antral domains of the stomach were already established by E10.5 ( Fig. 1a ). At that point in development, the canonical Wnt signalling pathway was active in the proximal stomach but exhibited little or no activity in the distal stomach 14 , as shown using the Wnt reporter mouse strain Axin2-lacZ ( Fig. 1b ). Although the regulation of Wnt/β-catenin signalling is known to play a role in establishing the pyloric-duodenal boundary 14, 15 , its role in gastric epithelial patterning had not been investigated. To determine whether Wnt/β-catenin signalling was functionally required for establishing the fundus in vivo, we deleted β-catenin (also known as Ctnnb1) in the foregut epithelium using Shh-cre (Shh-cre;β-catenin fl/fl ) to create conditional knockout (cKO) embryos. Disruption of Wnt/βcatenin signalling resulted in the loss of fundic identity, demonstrated by ectopic Pdx1 expression in the fundus at E10.5 (Fig. 1c ). Ectopic Pdx1 was initially restricted to the ventral half of the fundic epithelium, consistent with previously reported recombination activity using this Shh-cre line 16 , but it then expanded over time to include most of the proximal stomach and greater curvature by E14.5 (Extended Data Fig. 2a ). In addition, expression of the fundus markers Irx2, Irx3 and Irx5 was greatly reduced in the cKO embryos (Extended Data Fig. 2b ). Collectively, these data support the conclusion that epithelial Wnt/βcatenin signalling regulates gastric pattern formation, as it is required for the initial specification of fundus identity while repressing antral fate in the embryonic mouse stomach.
To understand the effect of early Wnt/β-catenin-mediated patterning abnormalities on subsequent cytodifferentiation, we analysed cKO embryos at E18.5. The stomach in cKO embryos was malformed and reduced in size at E18.5 ( Fig. 1d and Extended Data Fig. 2c-d ), which suggests that Wnt/β-catenin is involved in promoting stomach growth during later stages of development. Moreover, the stomach of cKO embryos was completely mis-patterned, with ectopic Pdx1 expression throughout the proximal-most regions of the epithelium (Fig. 1d ). Parietal cells, a fundic cell type marked by expression of Atp4b, were reduced in the cKO stomach ( Fig. 1d ) and completely absent in β-catenin-deficient epithelium ( Fig. 1e ). Those parietal cells that did develop were observed only in β-catenin-expressing epithelium that did not undergo Cre-mediated recombination ( Fig. 1e and Extended Data Fig. 2d, e ). Together, these in vivo data support a model in which Wnt/β-catenin signalling induces fundus specification and inhibits antral identity. Disruption of this early patterning coincides with subsequent cell-autonomous loss of parietal cells, suggesting that cytodifferentiation is impaired secondary to develop mental patterning defects.
Differentiation of fundic hGOs from hPSCs
We next investigated the role of Wnt/β-catenin signalling in establishing the fundic-antral pattern of the developing human stomach. To model the early stages of stomach differentiation, we started with a previously described protocol for differentiating hPSCs into antrum-like gastric organoids, which recapitulates the normal stages of early gastric development with high fidelity 7 . Starting with three-dimensional posterior foregut spheroids (SOX2 + HNF1β + ), we tested whether stimulation of Wnt/β-catenin signalling would direct posterior foregut epithelium into the fundic (SOX2 + GATA4 + PDX1 − ) rather than antrum (SOX2 + GATA4 + PDX1 + ) lineage during the gastric specification stage ( Fig. 2a ). Indeed, activation of β-catenin with the GSK3β inhibitor CHIR99021 (CHIR) for three days resulted in nearly complete repression of PDX1 expression at day 9, accompanied by significantly increased expression of IRX2, IRX3 and IRX5 (Fig. 2b, c ; P < 0.05). Importantly, levels of SOX2 and GATA4 were unaffected by CHIR treatment, confirming that spheroids retained their gastric identity. Thus, CHIR exposure resulted in the formation of SOX2 + GATA4 + PDX1 − epithelium with increased IRX gene family expression, a signature consistent with the presumptive fundic epithelium.
We then sought to determine whether CHIR-treated spheroids would further develop into more mature hGOs containing a fundus-like epithelium. Notably, a three-day pulse of CHIR from days 6-9 was not sufficient to irreversibly specify a fundic identity, as the hGOs ultimately reverted to a PDX1 + antral phenotype at later stages. However, continued Wnt stimulation via CHIR treatment through at least day 29 led to stable induction of fundic gene expression (Extended Data Fig. 3a ). This was consistent with the prolonged activity of Wnt/β-catenin signalling during embryonic stomach development in vivo. Although previous studies indicated that ectopic Wnt activation in the embryonic stomach promoted an intestinal fate 14, 15 , CHIR-treated hGOs did not exhibit a significant increase in the intestinal markers CDX2, MUC2, CCK and SCT (Extended Data Figs 3e, 4a, b). We further demonstrated that CDX2 remained suppressed despite Wnt/β-catenin activation owing to concomitant inhibition of BMP signalling, as replacing Noggin with BMP4 led to robust expression of the intestinal transcription factor (Extended Data Fig. 4c ).
Once regional domains have been established in early development, the primitive gastric epithelium undergoes periods of growth, glandular morphogenesis, and differentiation of definitive cell types. We have previously shown that hAGOs undergo a similar progression of morphologic and cellular development 7 . CHIR-treated hFGOs grew at a similar rate and efficiency compared to hAGOs, as 75-90% of all spheroids plated grew into organoids (Extended Data Fig. 3d ). At day 20, both types of hGOs contained epithelia that expressed the gastric SOX2-GATA4 signature in more than 90% of cells, while PDX1 was restricted to hAGOs (87.1 ± 8.4% in hAGOs and 3.9 ± 2.0% in hFGOs, P = 3.07 × 10 −6 ; Extended Data Fig. 3e ). The organoids maintained their respective gastric identities throughout their development (Extended Data Fig. 3b , c). By day 34, hFGOs and hAGOs comprised CDH1 + CTNNB1 + KRT8 + polarized, columnar epithelia Article reSeArcH that ubiquitously expressed the gastric-specific 17 claudin CLDN18 ( Fig. 2e and Extended Data Fig. 4d ), as well as comparable undifferentiated mesenchymal cells (Extended Data Fig. 5b ). One notable difference was that hFGOs had a distinctive architecture with organized glands that budded from the organoid epithelium ( Fig. 2d , e and Extended Data Fig. 5a ), whereas hAGOs had complex folding and primitive gland-like organization but rarely glandular buds 7 . Thus, the novel Wnt/β-catenin-dependent mechanism that specifies the fundus is conserved in humans and can be manipulated to generate three-dimensional hFGOs with a glandular epithelium that molecularly resembles the developing fundus.
Region-specific gastric cytodifferentiation
Differentiated gastric cell types were first detected in hGOs at around day 27 and then increased by day 34 7 , analogous to the first few weeks of postnatal development in the mouse stomach 18 . At day 34, hFGOs contained both MUC5AC + surface mucous cells and MUC6 + mucous neck cells, as expected, similar to the hAGOs (Fig. 3a, b and Extended Data Fig. 6a ). hFGOs also formed a variety of endocrine cell types ( Fig. 3c ), but expression of the hormone GAST was specific to hAGOs and GHRL expression was enriched tenfold in hFGOs ( Fig. 3d) , consistent with the normal gastroendocrine pattern 19 .
To functionally define the region-specific competence of hGOs, we used an inducible system to overexpress the proendocrine transcription factor NEUROG3 in a NEUROG3-deficient PSC line. Expression of NEUROG3 in both hGO subtypes resulted in robust expression of the pan-endocrine marker SYP and the common gastric hormones SST and GHRL (Extended Data Fig. 6c ). However, only the hAGOs, and not the hFGOs, were able to give rise to GAST-expressing G-cells ( Fig. 3e and Extended Data Fig. 6c ), consistent with the antrum-specific distribution of G-cells in the human stomach 19 .
Chief cells, the fundus-specific secretory lineage, reside in the bases of oxyntic glands and have been proposed to represent a type of reserve stem cell 20 . hFGOs exhibited epithelial expression of the chief cell-specific 21 transcription factor MIST1 ( Fig. 4a ), had 100-1,000-fold increases in transcripts for the proenzymes PGA5 and PGC (Fig. 4c ), and contained significantly increased pepsinogen content as measured by ELISA ( Fig. 4e ). However, the levels of PGA5 and PGC transcripts were less than 1% those found in the adult human stomach (Extended Data 6d), and pepsinogen-positive cells were only rarely detectable by immunohistochemistry ( Fig. 4b, c ). Consistent with this, zymogen granule-containing cells 22 were identified by transmission electron microscopy (TEM) ( Fig. 4d ) but were rare. By contrast, cells with a more immature mucous granule pattern were abundant (Extended Data Fig. 6b ). As chief cells in vivo do not exhibit robust pepsinogen expression for the first few weeks of life (Extended Data Fig. 7a , b), we concluded that the chief cells were present in hFGOs but were immature. hFGOs therefore represent a robust platform in which to dissect the intrinsic and extrinsic mechanisms that regulate chief cell maturation.
Pathways controlling parietal cell differentiation
At baseline, hFGOs contained only a small number of parietal cells ( Fig. 5a, b ), the defining cell type of fundic glands that acidify the gastric lumen via the proton pump (which consists of ATP4A and ATP4B subunits). Identification of efficient methods to increase parietal cell populations has remained elusive owing to a lack of understanding of the signalling mechanisms that drive their development.
We therefore used PSC-derived hFGOs as a platform to functionally screen candidate signalling pathways for a role in regulating parietal cell differentiation. We exposed day 30 hFGOs to signalling agonists or antagonists for 2 days and analysed parietal cell differentiation on day 34. Whereas the majority of signalling manipulations had no appreciable effect, transient inhibition of the MEK pathway with PD0325901 (PD03) resulted in substantial upregulation of both ATP4A and ATP4B (Extended Data Fig. 8a ). Furthermore, while BMP4 alone did not affect parietal cell gene expression, it could enhance the effect of PD03 (data not shown). Thus, a two-day pulse of PD03 and BMP4 was sufficient to induce rapid and robust expression of the parietal cell markers ATP4A, ATP4B and GIF (Fig. 5a, b and Extended Data Fig. 8d ). Interestingly, this effect was not induced by simply removing EGF or FGF from the culture medium (Extended Data Fig. 8b ), suggesting that there are likely to be endogenous signalling interactions upstream of MEK/ERK that are responsible for limiting parietal cell differentiation in hFGO cultures. Furthermore, treatment with PD03 and BMP4 affected only the parietal cell lineage (Extended Data Fig. 8e ), and was unable to induce parietal cells in hAGOs (Extended Data Fig. 8c ), further emphasizing that early patterning of the gastric epithelium defines its ultimate differentiation potential.
At day 34, hFGO epithelia showed organization similar to that of the human stomach, with mucous cells lining the surface domain and parietal cells concentrated in the glandular portion (Fig. 5e ). Moreover, parietal cell morphology closely resembled that of maturing parietal cells in vivo (Fig. 5c ). Given their resemblance to parietal cells in vivo and their tubulovesicular ultrastructure as seen on TEM (Fig. 5d ), we hypothesized that the parietal cells in hFGOs would be able to secrete acid in response to appropriate stimuli. Measured using a pH-sensitive dye (SNARF5F) with real-time confocal microscopy (Extended Data Fig. 9a ), hFGOs produced a swift and marked decrease in luminal pH in response to histamine that was blocked by either the H 2 antagonist famotidine or the H + K + -ATPase antagonist omeprazole ( Fig. 5f and Extended Data Fig. 9b ). To visualize the cellular response to histamine, hGOs were cultured with the fluorescent dye acridine orange, which shifts to an orange colour when sequestered in acidic compartments 23 . Similar to isolated mouse gastric glands, acridine orange accumulated in acidified cellular vesicles in hFGO glands in response to histamine ( Fig. 5g and Extended Data Fig. 9c, d) . These data indicate that the parietal cells underwent appropriate changes in secretory canalicular structure in response to acid-inducing stimuli.
In vivo, differentiated gastric cell lineages are thought to derive from a common pool of undifferentiated stem or progenitor cells. Here we have shown that the relative proportions of cell types in hFGOs can be altered either through genetic means (NEUROG3-mediated regulation of endocrine cells) or by manipulation of extrinsic signalling pathways (PD03 and BMP4 for parietal cells). These observations led to the hypothesis that hFGOs might contain a population of gastric stem cells analogous to those that have been isolated from the adult stomach. Indeed, we found that dissociated day 34 hFGOs could be passaged serially to give rise to new organoids (Extended Data Fig. 10a, b ). Re-growth of organoids from passaged hFGOs was dependent on high-Wnt and high-FGF culture medium, similar to what is used to grow primary gastric tissue organoids 24, 25 . Following two rounds of passaging, hFGOs maintained expression of the lineage markers MUC5AC, MUC6, PGC, and GHRL; however, they did not contain parietal cells and were refractory to PD03-BMP4-mediated induction of the parietal lineage (Extended Data Fig. 10c, d) . This finding was similar to what has been observed in adult stem cell-derived gastric organoids, which do not robustly produce parietal cells despite being derived from the bona fide oxyntic mucosa 20, 26 . Thus it will be important to identify conditions that preserve parietal cell competence in long-term cultures of hGOs and adult gastric organoids.
Summary
To our knowledge, this is one of the first studies in which combined in vivo and in vitro methods have been directly applied to the differentiation of hPSCs into a new tissue type. We have shown that Wnt/β-catenin signalling is involved in specifying the fundic domain during stomach development in mice, and used Wnt modulation as the mecha nistic basis to direct differentiation of hPSCs into threedimensional human fundic organoids. In both mouse and human, Wnt-mediated fundus specification was required for the subsequent formation of parietal cells. The fundus-specific manipulations at each stage of this directed differentiation protocol were essential for robust parietal cell induction (Extended Data Fig. 8f ), emphasizing the importance of methodically reproducing the embryonic signalling environment. Previous reports have shown that the mesenchymal factor Barx1 acts indirectly to repress Wnt signalling and thereby helps to prevent intestinal gene expression in the stomach 14, 15 . Given that we have identified an epithelial Wnt/β-catenin function, and the previous work identified a mesenchymal pathway, it seems likely that Wnt/β-catenin may have distinct roles in the epithelium and mesenchyme. For example, the mesenchymal role for Wnt/β-catenin could modulate other signalling pathways such as BMP 27 , which our data show synergizes with Wnt to promote intestinal specification from early endoderm 7 (Extended Data Fig. 4c ). The human gastric organoid systems might be useful, in combination with animal models, to dissect how these signalling pathways interact in the mesenchyme and epithelium to coordinate early embryonic gastrointestinal development.
Our understanding of pathways that control the differentiation of gastric progenitor cells into distinct lineages is also incomplete. Our hGO platform has shown that MEK/ERK signalling potently represses parietal cell specification. Consistent with these findings, transgenic activation of MEK/MAPK-dependent pathways led to loss of parietal cells in vivo 28, 29 . Therefore, hGOs are a tractable human model system in which to identify and study signalling mechanisms involved in normal cellular homeostasis in the fundus and antrum. Furthermore, aberrant regulation of developmental programs may also contribute to gastric disease, as corpus and/or fundus pathology is often associated with parietal cell atrophy [30] [31] [32] , antral-type histology 33 , and even misexpression of Pdx1 34 . Thus, targeting of these pathways could have clinical applications, as Choi et al. recently demonstrated that pharmacologi cal inhibition of MEK was sufficient to restore normal parietal cell differentiation in a mouse model of metaplasia 35 . Additionally, having now established both antral-and fundic-type hGOs, it is possible to study how these human gastric tissues interact physiologically, react differentially to infection and injury, and respond to pharmacological treatments.
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Mouse experiments. The following genetic mouse strains were obtained from The Jackson Laboratory, housed at Cincinnati Children's Hospital Research Foundation animal facility, and maintained according to IACUC protocol (0B09074): Axin2:LacZ (stock no. 009120), Shh:Cre (stock no. 005622), and β-catenin floxed (stock no. 004152). Timed matings, with the morning the vaginal plug was observed being denoted as E0.5, were used to generate embryos at various stages that were used for either wholemount staining or tissue dissection. At least two litters of embryos were analysed at each developmental stage examined. Both male and female embryos were analysed. Pluripotent stem cell culture. Human embryonic stem cell line WA01 (H1; obtained from WiCell) was supplied by the Pluripotent Stem Cell Facility at Cincinnati Children's Hospital Medical Center. Cell identity was confirmed by short tandem repeat analysis (Microsatellite STR Analysis; Applied Biosystems), and cells were routinely tested for mycoplasma contamination (MycoAlert Mycoplasma Detection Kit; Lonza). Pluripotent cells were maintained in feederfree conditions on HESC-qualified Matrigel (BD Biosciences) in mTesR1 media (Stem Cell Technologies). Colonies were passaged every four days using dispase (Invitrogen). Differentiation of posterior foregut spheroids. The protocol for directed differentiation of gastric organoids was adapted from our previous protocol 7 , and Supplementary Table 1 contains the complete list of media and growth factors for each stage. For differentiation, hPSCs were dissociated into single cells using Accutase (Stem Cell Technologies) and plated into 24-well plates at a density of roughly 200,000 cells per well in mTesR1 with Y-27632 (10 μM; Stemgent). The following day, cells were differentiated into definitive endoderm (DE) by adding Activin A (100 ng/ml; Cell Guidance Systems) in RPMI 1640 medium (Invitrogen) for three days. The medium was also supplemented with NEAA (1×; Gibco) and defined FBS (dFBS; Invitrogen) at 0%, 0.2%, and 2.0% on days 1, 2, and 3, respectively. Additionally, BMP4 (50 ng/ml; R&D Systems) was added on the first day. Subsequently, DE was differentiated to posterior foregut endoderm by exposing cells to CHIR99021 (2 μM; Stemgent), FGF4 (500 ng/ml; R&D Systems), and noggin (200 ng/ml; R&D systems) for three days in RPMI 1640 supplemented with NEAA and 2.0% dFBS. Retinoic acid (2 μM; Sigma Aldrich) was added for the final day. The medium was changed every day. This process resulted in the spontaneous formation of three-dimensional posterior foregut spheroids. Three-dimensional culture of foregut spheroids-gastric organoids. Posterior foregut spheroids were collected and transferred to a three-dimensional culture system as previously described 36 . Briefly, spheroids were suspended in 50 μl Matrigel (BD Biosciences) and plated as droplets into 24-well plates. The matrigel was allowed to solidify for 10 min in the tissue culture incubator, then overlayed with basic gut medium (BGM) containing growth factors and/or small molecule agonists. BGM consisted of Advanced DMEM/F12 medium (Gibco) supplemented with N2 (1×; Invitrogen), B27 (1×; Invitrogen), HEPES (10 μM; Gibco), l-glutamine, penicillin/streptomycin, and EGF (100 ng/ml; R&D Systems). During days 6-9, spheroids were cultured with RA and noggin to specify the antral lineage. For fundic specification, CHIR was added during this stage. Antral hGOs were subsequently cultured in BGM with only EGF. Fundic hGOs were continuously exposed to CHIR from day 6 to day 30. In addition, FGF10 (50 ng/ml; R&D Systems) was added to fundic hGOs from day 20 to day 30 as it was shown to enhance the glandular morphogenesis driven by CHIR (data not shown). On day 20, organoids were collected and re-plated at a dilution of 1:10-1:20.
For screening experiments to identify factors that increase parietal cell differentiation, hFGOs were grown to day 30, then exposed for two days to individual signalling pathway agonists and antagonists: DAPT (1 μM; Stemgent), SB431542 (10 μM; Stemgent), BMP4 (50 ng/ml; R&D Systems), PD0325901 (2 μM; Stemgent), gastrin (10 nM; Sigma Aldrich), dexamethasone (50 nM; Sigma Aldrich), and Wnt5a (50 ng/ml; R&D Systems). Following treatment, hFGOs were grown for two more days to day 34, then analysed by qPCR. RNA isolation and qPCR. Total RNA was isolated using Nucleospin RNA II kit (Machery Nagel) and converted to cDNA as previously described 7 . qPCR was performed on Quantstudio 6 (Applied Biosystems) using Quantitect SYBR-Green master mix (Qiagen), and primer sequences are listed below. Primer sequences. Primers used for qPCR were the following: hATP4A, forward 5′-TGGTAGTAGCCAAAGCAGCC-3′, reverse 5′-TGCCATCCAGGC TAGTGAG-3′; hATP4B, forward 5′-ACCACGTAGAAGGCCACGTA-3′, reverse 5′-TGGAGGAGTTCCAGCGTTAC-3′; hAXIN2, forward 5′-CTGGT GCAAAGACATAGCCA-3′, reverse 5′-AGTGTGAGGTCCACGGAAAC-3′; hCCK, forward 5′-CGGTCACTTATCCTGTGGCT-3′, reverse 5′-CTGCGA AGATCAATCCAGCA-3′; hCDX2, forward 5′-CTGGAGCTGGAGAAG GAGTTTC-3′, reverse 5′-ATTTTAACCTGCCTCTCAGAGAGC-3′; hCHGA, forward 5′-TGACCTCAACGATGCATTTC-3′, reverse 5′-CTGTCCTGGCT CTTCTGCTC-3′; hGAPDH, forward 5′-CCCATCACCATCTTCCAGGAG-3′, reverse 5′-CTTCTCCATGGTGGTGAAGACG-3′; hGAST, forward 5′-CAGA GCCAGTGCAAAGATCA-3′, reverse 5′-AGAGACCTGAGAGGCACCAG-3′; hGATA4, forward 5′-TCCAAACCAGAAAACGGAAGC-3′, reverse 5′-GCC CGTAGTGAGATGACAGG-3′; hGHRL, forward 5′-GCTGGTACTGAAC CCCTGAC-3′, reverse 5′-GATGGAGGTCAAGCAGAAGG-3′; hGIF, forward 5′-CATTTTCCGCGATATTGTTG-3′, reverse 5′-GCACAGCGCAAAAAT CCTAT-3′; hIRX2, forward 5′-GTGGTGTGCGCGTCGTA-3′, reverse 5′-GGC GTTCAGCCCCTACC-3′; hIRX3, forward 5′-GGAGAGAGCCGATAAGACCA-3′, reverse 5′-AGTGCCTTGGAAGTGGAGAA-3′; hIRX5, forward 5′-GGTG TGTGGTCGTAGGGAGA-3′, reverse 5′-GCTACAACTCGCACCTCCA-3′; hMIST1, forward 5′-TGCTGGACATGGTCAGGAT-3′, reverse 5′-CGGAC AAGAAGCTCTCCAAG-3′; hMUC2, forward 5′-TGTAGGCATCGCT CTTCTCA-3′, reverse 5′-GACACCATCTACCTCACCCG-3′; hMUC5AC, forward 5′-CCAAGGAGAACCTCCCATAT-3′, reverse 5′-CCAAGCGT CATTCCTGAG-3′; hMUC6, forward 5′-CAGCAGGAGGAGATCACGTTC AAG-3′, reverse 5′-GTGGGTGTTTTCCTGTCTGTCATC-3′; hPDX1, forward 5′-CGTCCGCTTGTTCTCCTC-3′, reverse 5′-CCTTTCCCATGGATGAAGTC-3′; hSCT, forward 5′-GGTTCTGAAACCATAGGCCC-3′, reverse 5′-GTCAGGG TCCAACATGCC-3′; hSOX2, forward 5′-GCTTAGCCTCGTCGATGAAC-3′, reverse 5′-AACCCCAAGATGCACAACTC-3′; mCdx2, forward 5′-TCTG TGTACACCACCCGGTA-3′, reverse 5′-GAAACCTGTGCGAGTGGATG-3′; mGata4, forward 5′-CCATCTCGCCTCCAGAGT-3′, reverse 5′-CTGGAAGA CACCCCAATCTC-3′; mGapdh, forward 5′-TTGATGGCAACAATCTCCAC-3′, reverse 5′-CGTCCCGTAGACAAAATGGT-3′; mIrx1, forward 5′-AATAAG CAGGCGTTGTGTGG-3′, reverse 5′-CTCAGCCTCTTCTCGCAGAT-3′; mIrx2, forward 5′-AGCTGGTATGGATAGGCCG-3′, reverse 5′-GGCTTCCC GTCCTACGTG-3′; mIrx3, forward 5′-ATAAGACCAGAGCAGCGTCC-3′, reverse 5′-GTGCCTTGGAAGTGGAGAAA-3′; mIrx5, forward 5′-GGAGT GTGGTCGTAGGGAGA-3′, reverse 5′-GCTACAACTCGCACCTCCA-3′; mPdx1, forward 5′-ACGGGTCCTCTTGTTTTCCT-3′, reverse 5′-TGGATGAA ATCCACCAAAGC-3′; mPitx1, forward 5′-GTCCATGGAGGTGGGGAC-3′, reverse 5′-GCTTAGGCGCCACTCTCTT-3′; mSox2, forward 5′-AAAGCG TTAATTTGGATGGG-3′, reverse 5′-ACAAGAGAATTGGGAGGGGT-3′; mTrp63, forward 5′-AGCTTCTTCAGTTCGGTGGA-3′, reverse 5′-CCTCC AACACAGATTACCCG-3′. Immunofluorescent staining. Tissues were fixed in 4% paraformaldehyde overnight at 4 °C, then washed thoroughly in PBS. For wholemount immunofluorescent staining, embryos were processed as previously described 37 . Briefly, they were permeabilized in Dent's bleach (4:1:1 EtOH:DMSO:30% H 2 O 2 ) for 2 h at room temperature and rehydrated through series of methanol washes. Embryos were then blocked for 1 h, incubated in primary antibody overnight at 4 °C, washed in PBS, incubated in secondary antibody overnight at 4 °C, and thoroughly washed. For paraffin embedding, tissues were dehydrated through series of ethanol washes, washed in xylene, then embedded in paraffin. For staining, slides were deparaffinized and rehydrated. Antigen retrieval was performed in citrate buffer for 45 min in steamer. Primary antibodies were incubated overnight at 4 °C. Following primary antibody, slides were washed in PBS then incubated with secondary antibody (at dilution of 1:500) for 1 h at room temperature. Secondary antibodies (Jackson ImmunoResearch Laboratories) were made in donkey and conjugated to Alexa Fluor 488, 594, or 647. Primary antibodies. Antibodies used for immunofluorescent staining are listed with antigen, host species, manufacturer and catalogue number, and dilution used for staining. Atp4b, rabbit, Santa Cruz sc84304, 1:500; Cdh1, goat, R&D Systems AF648, 1:500; Cdh1, mouse, BD Imaging. Confocal imaging was performed on a Nikon A1Rsi inverted confocal microscope. For whole-mount imaging, embryos were dehydrated in methanol and cleared in Murray's clear (2:1 benzyl benzoate:benzyl alcohol) just before imaging. After staining, slides were mounted with Fluoromount G (SouthernBiotech), and air-dried overnight at room temperature. Transmission electron microscopy. For transmission electron microscopy, hGOs were processed as previously described 7 . Briefly, organoids were fixed in 3% glutaraldehyde, washed in 0.1 M sodium cacodylate buffer, and incubated for 1 h in 4% osmium tetroxide. They were subsequently washed then dehydrated in ethanol series, and finally embedded in propylene oxide/LX112. Tissue was then sectioned and stained with 2% uranyl acetate followed by lead citrate. Images were visualized on Hitachi transmission electron microscope. Pepsinogen ELISA. ELISA was performed using the Human Pepsinogen I (PGI) ELISA Kit (Thermo Scientific, EHPGI) according to the manufacturer's instructions. Briefly, day 34 hGOs were collected and incubated in Cell Recovery Solution (Corning) for 1 h at 4 °C then washed in PBS. Organoids were lysed with RIPA buffer followed by vigorous vortexing at high velocity for 30 min at room temperature. Lysates were pelleted and supernatant was collected and stored at −80 °C. For ELISA, the samples and standards were performed in technical replicates. The reactions were measured on a μQuant microplate plate reader (Bio Tek). Absorbance at 450 nm was measured, and the 570 nm absorbance was subtracted. Acid secretion assays. Acid secretion assays were performed as previously described 24 . hGOs were grown in the chambered coverglass (Thermo Scientific) and the chamber was placed on an inverted confocal microscope (Zeiss LSM 710), and experiments were performed under 5% CO 2 at 37 °C (incubation chamber, PeCon).
Freshly isolated mouse gastric fundic glands or cultured hGO were incubated with acridine orange (10 μM), then acridine orange fluorescence was excited at 458 nm or 488 nm and images were collected at 600-650 nm (red) or 500-550 nm (green), respectively. On the other hand, to monitor the luminal pH of hGOs, the ratiometric pH-sensitive dye, 5-(and-6)-carboxy SNARF-5F (5 mM stock: EX 560 nm, EM 565-605 (green) and 620-680 (red) nm: Invitrogen) was microinjected (46-92 nl) into the lumen and monitored. Fluorescent dye was also added to the medium. Histamine (100 μM; Sigma) was added to the medium, while famotidine (100 μM; Sigma) or omeprazole (100 μM; Sigma) were pre-incubated for at least 30 min before histamine. Images were analysed using MetaMorph software (Molecular Devices). Background corrected 620-680/565-605 nm ratio values were converted to pH using a standard curve. Statistical analysis. Statistical significance was determined using unpaired Student's t-test or one-way ANOVA with Dunnett's multiple comparison post-hoc test. P < 0.05 was considered significant. Statistics and experimental reproducibility. No statistical analysis was used to determine experimental sample size, no specific method of randomization was used, and the investigators were not blinded during experiments. Statistical methods and measures are described in the figure legends. The protocol for differen tiation of fundic hGOs was successfully completed more than 20 times by seven independent users in the laboratory. In all cases, data shown are derived from a single experiment that is representative of multiple experiments. 
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Extended Data Figure 3 | Stable induction of fundic fate in hGOs and efficiency of protocol. a, We investigated how long CHIR treatment was necessary to establish fundus identity. Brief CHIR treatment (days 6-9) and subsequent growth of organoids in control growth medium until day 34 resulted in fundic organoids expressing the antral marker PDX1, suggesting that short CHIR treatment did not produce a stable fundic fate. We then tested whether longer exposures to CHIR were required to retain fundic fate and found that only continuous treatment through at least day 29 could maintain low expression of the antral marker PDX1. *P < 0.05 compared to control antral hGOs; two-tailed Student's t-test. n = 3 biological replicates, data representative of two independent experiments. b, c, Over the course of the protocol, PDX1 remained low in CHIR-treated organoids, whereas IRX5 expression was persistently elevated. *P < 0.05; two-tailed Student's t-test; n = 3 biological replicates per time point. d, Conversion of day 6 posterior foregut spheroids to early stage gastric organoids (day 20) is greater than 80% efficient in both the hAGO and hFGO protocols. e, At d20, hFGO epithelium is ~90% GATA4 + SOX2 + PDX1 − whereas hAGO epithelium is ~90% GATA4 + SOX2 + PDX1 + . **P < 0.001, two-tailed Student's t-test, n = 4 biological replicates per experiment, two individual experiments shown. Scale bars, 100 μm (c) and 200 μm (d). 
